Arkkila P - Search Results

1

Outcome after discontinuation of TNFα-blocking therapy in patients with inflammatory bowel disease in deep remission.

Molander P, Färkkilä M, Salminen K, Kemppainen H, Blomster T, Koskela R, Jussila A, Rautiainen H, Nissinen M, Haapamäki J, Arkkila P, Nieminen U, Kuisma J, Punkkinen J, Kolho KL, Mustonen H, Sipponen T. Molander P, et al. Among authors: arkkila p. Inflamm Bowel Dis. 2014 Jun;20(6):1021-8. doi: 10.1097/MIB.0000000000000052. Inflamm Bowel Dis. 2014. PMID: 24798636 Clinical Trial.

2

Intestinal type of thromboangiitis obliterans (Buerger disease) preceding symptoms of severe peripheral arterial disease.

Arkkila PE, Kahri A, Färkkilä M. Arkkila PE, et al. Scand J Gastroenterol. 2001 Jun;36(6):669-72. Scand J Gastroenterol. 2001. PMID: 11424329

3

Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.

Arkkila PE, Seppälä K, Kosunen TU, Haapiainen R, Kivilaakso E, Sipponen P, Mäkinen J, Nuutinen H, Rautelin H, Färkkilä MA. Arkkila PE, et al. Am J Gastroenterol. 2003 Oct;98(10):2149-56. doi: 10.1111/j.1572-0241.2003.07682.x. Am J Gastroenterol. 2003. PMID: 14572560 Clinical Trial.

4

Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.

Arkkila PE, Seppälä K, Kosunen TU, Sipponen P, Mäkinen J, Rautelin H, Färkkilä M. Arkkila PE, et al. Eur J Gastroenterol Hepatol. 2005 Jan;17(1):93-101. doi: 10.1097/00042737-200501000-00018. Eur J Gastroenterol Hepatol. 2005. PMID: 15647648 Clinical Trial.

5

The clinical value of taking routine biopsies from the incisura angularis during gastroscopy.

Eriksson NK, Färkkilä MA, Voutilainen ME, Arkkila PE. Eriksson NK, et al. Among authors: arkkila pe. Endoscopy. 2005 Jun;37(6):532-6. doi: 10.1055/s-2005-861311. Endoscopy. 2005. PMID: 15933925

6

Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.

Arkkila PE, Seppälä K, Färkkilä MA, Veijola L, Sipponen P. Arkkila PE, et al. Scand J Gastroenterol. 2006 Jul;41(7):782-90. doi: 10.1080/00365520500463175. Scand J Gastroenterol. 2006. PMID: 16785190 Clinical Trial.

7

Prevalence and distribution of gastric intestinal metaplasia and its subtypes.

Eriksson NK, Kärkkäinen PA, Färkkilä MA, Arkkila PE. Eriksson NK, et al. Among authors: arkkila pe. Dig Liver Dis. 2008 May;40(5):355-60. doi: 10.1016/j.dld.2007.12.012. Epub 2008 Mar 4. Dig Liver Dis. 2008. PMID: 18291729

8

Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.

Nieminen U, Arkkila PE, Kärkkäinen P, Färkkilä MA. Nieminen U, et al. Among authors: arkkila pe. Liver Int. 2009 Feb;29(2):153-8. doi: 10.1111/j.1478-3231.2008.01779.x. Epub 2008 May 14. Liver Int. 2009. PMID: 18482270

9

Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey.

Haapamäki J, Turunen U, Roine RP, Färkkilä MA, Arkkila PE. Haapamäki J, et al. Among authors: arkkila pe. Scand J Gastroenterol. 2008;43(7):821-30. doi: 10.1080/00365520801912011. Scand J Gastroenterol. 2008. PMID: 18584521

10

Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease.

Haapamäki J, Turunen U, Roine RP, Färkkilä MA, Arkkila PE. Haapamäki J, et al. Among authors: arkkila pe. Qual Life Res. 2009 Oct;18(8):961-9. doi: 10.1007/s11136-009-9514-y. Epub 2009 Jul 23. Qual Life Res. 2009. PMID: 19629750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters